X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1749) 1749
Book Review (399) 399
Newspaper Article (321) 321
Publication (133) 133
Magazine Article (90) 90
Web Resource (51) 51
Trade Publication Article (41) 41
Newsletter (30) 30
Report (27) 27
Book Chapter (14) 14
Book / eBook (11) 11
Conference Proceeding (10) 10
Government Document (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1304) 1304
botulinum toxin (1080) 1080
humans (899) 899
food science & technology (356) 356
female (352) 352
animals (339) 339
male (327) 327
biotechnology & applied microbiology (320) 320
botulinum toxins, type a - therapeutic use (279) 279
microbiology (270) 270
clostridium botulinum (242) 242
double-blind (241) 241
adult (237) 237
middle aged (234) 234
food microbiology (226) 226
treatment outcome (220) 220
research (208) 208
clinical neurology (201) 201
care and treatment (184) 184
clostridium-botulinum (178) 178
aged (175) 175
analysis (174) 174
neuromuscular agents - therapeutic use (164) 164
botulism (163) 163
botulinum toxins, type a - administration & dosage (142) 142
quality of life (142) 142
medicine & public health (134) 134
temperature (134) 134
botulinum toxins - therapeutic use (130) 130
bacteria (129) 129
time factors (125) 125
migraine (124) 124
toxins (124) 124
quality-of-life (123) 123
mice (119) 119
growth (117) 117
clostridium botulinum - growth & development (116) 116
surgery (114) 114
pain (112) 112
spasticity (110) 110
clostridium botulinum - metabolism (109) 109
usage (108) 108
health aspects (104) 104
neurosciences (104) 104
clostridium botulinum - isolation & purification (103) 103
toxin (101) 101
rehabilitation (100) 100
pharmacology & pharmacy (95) 95
toxin type-a (93) 93
prevalence (92) 92
efficacy (91) 91
food (90) 90
toxin production (90) 90
botulinum toxins, type a - economics (89) 89
spores (89) 89
botulinum toxins - biosynthesis (88) 88
injections (88) 88
drug therapy (87) 87
patients (87) 87
neurology (86) 86
stroke (86) 86
management (85) 85
clinical trials (84) 84
urinary incontinence (81) 81
safety (80) 80
placebo-controlled trial (79) 79
clostridium botulinum - genetics (77) 77
neuromuscular agents - administration & dosage (77) 77
abridged index medicus (76) 76
medical research (76) 76
urology & nephrology (76) 76
cervical dystonia (75) 75
dermatology (75) 75
listeria-monocytogenes (75) 75
onabotulinumtoxina (74) 74
medicine (71) 71
chronic disease (69) 69
botulinum toxins (68) 68
botulinum-toxin (68) 68
hydrogen-ion concentration (68) 68
fda approval (67) 67
botulinum-toxin-a (65) 65
colony count, microbial (65) 65
overactive bladder (65) 65
pharmaceutical industry (65) 65
risk factors (65) 65
cost-benefit analysis (64) 64
botulinum toxin type a (63) 63
botulinum toxins - analysis (63) 63
diagnosis (63) 63
methods (63) 63
muscle spasticity - drug therapy (63) 63
adolescent (62) 62
toxicology (62) 62
injection (61) 61
stock exchanges (60) 60
spores, bacterial - growth & development (59) 59
studies (59) 59
therapy (59) 59
botulinum toxins, type a - adverse effects (58) 58
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2266) 2266
German (16) 16
Turkish (9) 9
French (8) 8
Spanish (7) 7
Polish (5) 5
Czech (2) 2
Japanese (2) 2
Norwegian (2) 2
Portuguese (2) 2
Russian (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF DRUGS IN DERMATOLOGY, ISSN 1545-9616, 09/2017, Volume 16, Issue 9, pp. 936 - 938
In their article "Importing Injectables" in the September 2014 issue of the Journal of Drugs in Dermatology, Dr. Kenneth Beer and Karen Rothschild highlighted... 
DERMATOLOGY | Cosmetic Techniques - standards | Neuromuscular Agents - standards | Cosmetic Techniques - economics | Neuromuscular Agents - economics | Humans | Counterfeit Drugs - administration & dosage | Botulinum Toxins - economics | Botulinum Toxins - standards | Counterfeit Drugs - economics | Commerce - standards
Journal Article
Toxins, ISSN 2072-6651, 03/2013, Volume 5, Issue 4, pp. 776 - 783
Journal Article
Trials, ISSN 1745-6215, 03/2016, Volume 17, Issue 1, pp. 129 - 129
Background: Blepharospasm and hemifacial spasm are debilitating conditions that significantly impact on patient quality of life. Cyclical treatment with... 
Hemifacial spasm | Illness perceptions | Patient-led care | Randomised controlled trial | Protocol | Botulinum toxin | Acceptability | Blepharospasm | Quality of life | RHEUMATOID-ARTHRITIS | MEDICINE, RESEARCH & EXPERIMENTAL | DEPRESSION SCALE | EFFICACY | ANXIETY | SAFETY | HOSPITAL FOLLOW-UP | CRANIOCERVICAL DYSTONIA | INSTRUMENT | QUALITY-OF-LIFE | CERVICAL DYSTONIA | Drug Costs | Acetylcholine Release Inhibitors - economics | Humans | Patient Participation | Clinical Protocols | Cost of Illness | Acetylcholine Release Inhibitors - administration & dosage | Acetylcholine Release Inhibitors - adverse effects | Affect | Patient Satisfaction | Blepharospasm - diagnosis | Time Factors | Hemifacial Spasm - drug therapy | Botulinum Toxins - economics | Interviews as Topic | Surveys and Questionnaires | Botulinum Toxins - adverse effects | Botulinum Toxins - administration & dosage | Disability Evaluation | Severity of Illness Index | Drug Administration Schedule | Blepharospasm - economics | Treatment Outcome | Hemifacial Spasm - diagnosis | Blepharospasm - drug therapy | Hemifacial Spasm - economics | Cost-Benefit Analysis | London | Quality of Life | Appointments and Schedules | Research Design | Complications and side effects | Usage | Care and treatment | Eyelid diseases | Patient outcomes | Clinical trials | Research | Index Medicus
Journal Article
Acta Neurologica Scandinavica, ISSN 0001-6314, 01/2014, Volume 129, Issue 1, pp. 13 - 20
Journal Article
Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 06/2014, Volume 133, Issue 6, pp. 783e - 789e
Journal Article
Annals of Plastic Surgery, ISSN 0148-7043, 03/2018, Volume 80, Issue 3, pp. 287 - 289
INTRODUCTIONClostridium botulinum toxin is effective through cleaving presynaptic proteins at the neuromuscular junction, which prevents the release of... 
syringe | cost-effective | onabotulinumtoxinA | DEAD SPACE | SURGERY | Syringes - classification | Cost-Benefit Analysis | Humans | Syringes - economics | Botulinum Toxins, Type A - economics | Injections, Intramuscular | Botulinum Toxins, Type A - administration & dosage | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.